| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-09 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.39 | 2e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.31 | 3e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-09 |